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Abstract	
Obesity	is	a	critical	component	of	metabolic	syndrome,	a	group	of	interrelated	conditions	
that	significantly	increase	the	risk	of	developing	cardiovascular	disease,	type	2	diabetes	
and	non–alcoholic	fatty	liver	disease.	Dietary	interventions	have	been	extensively	studied	
in	the	treatment	of	metabolic	syndrome,	however,	few	studies	have	investigated	the	rate	
at	which	 healthy	 dietary	 changes	 reverse	 the	 symptoms	 of	metabolic	 syndrome.	 This	
study	aimed	to	investigate	the	sequence	of	metabolic,	cardiovascular	and	hepatic	changes	
that	occur	over	time	in	obese	rats	that	have	been	switched	to	a	healthier	diet.	Male	Wistar	
rats	aged	8–9	weeks	were	fed	a	high–carbohydrate,	high–fat	diet	for	8	weeks,	which	was	
then	replaced	with	a	low–fat	corn	starch	diet	for	an	additional	1,	2,	4	or	8	weeks.	Diet–
induced	 changes	were	 analysed	 in	 comparison	 to	 control	 rats	 that	were	 fed	 the	 corn	
starch	diet	for	16	weeks	and	the	high–carbohydrate,	high–fat	diet	for	8	and	16	weeks.	
Symptoms	of	metabolic	syndrome	were	evident	after	8	weeks	of	consuming	the	high–
carbohydrate,	high–fat	diet	and	worsened	with	continued	consumption	of	this	diet.	Daily	
energy	intake	rapidly	decreased	after	switching	to	the	corn	starch	diet	and	throughout	
the	final	8	weeks	of	protocol	remained	consistent	with	the	rats	that	had	never	been	fed	
the	high–carbohydrate,	 high–fat	 diet.	Within	 the	 first	week	of	 the	diet	 switch,	 plasma	
triglycerides	were	halved	and	there	was	a	significant	decrease	in	omental	fat,	kidney	and	
liver	tissue	weights.	Diastolic	stiffness,	heart	inflammation	and	liver	fat	deposition	were	
markedly	 decreased	 2	weeks	 after	 the	 diet	 switch,	while	 systolic	 blood	 pressure	was	
significantly	reduced	after	4	weeks.	These	improvements	were	maintained	8	weeks	after	
switching	to	the	corn	starch	diet,	despite	the	rats	regaining	body	weight	within	4–6	weeks	
of	the	diet	switch,	and	there	was	also	a	decrease	in	plasma	non–esterified	fatty	acids	and	
abdominal	fat	mass.	Based	on	these	results,	switching	from	a	high–calorie	diet	containing	
 large	amounts	of	saturated	fats,	fructose	and	sucrose	to	a	low–fat	diet	that	was	rich	in	
complex	carbohydrates	alleviated	the	symptoms	of	metabolic	syndrome	by	decreasing	
abdominal	adiposity,	which	in	turn	reduced	cardiac	inflammation,	improved	ventricular	
function	and	lowered	hepatic	fat	deposition.		
	
	
Keywords:	 diet	 switch,	 low–fat	 diet,	 obesity,	 metabolic	 syndrome,	 cardiovascular	
disease,	inflammation	
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Chapter	1. 	 Introduction	and	literature	review	
1.1	 The	burden	of	obesity	
The	global	prevalence	of	obesity	has	almost	tripled	within	four	decades,	increasing	from	
5%	 in	1975	 to	13%	 in	2014,	 and	 is	 expected	 to	 reach	20%	by	2025	 if	 current	 trends	
continue	 (NCD	 Risk	 Factor	 Collaboration	 2016).	 Although	 several	 gene	 variants	 are	
known	to	influence	individual	susceptibility	to	obesity,	this	rapid	rise	in	obesity	cannot	
be	solely	attributed	to	genetics	(Swinburn	et	al.	2011).	The	increasing	predominance	of	
unhealthy	lifestyles,	which	typically	consist	of	prolonged	physical	inactivity	and	frequent	
consumption	of	palatable,	energy–dense	foods,	has	strongly	contributed	to	the	growing	
obesity	epidemic	in	modern	society	(Vandevijvere	et	al.	2015).		
	
Almost	5	million	Australian	adults	are	obese	and	an	additional	6	million	are	classed	as	
overweight,	which	 equates	 to	 63%	of	 the	 adult	 population.	High	body	 fat	 is	 a	 leading	
preventable	risk	factor	for	disease	burden	in	Australia,	second	only	to	tobacco	smoking,	
and	the	majority	of	this	burden	is	attributed	to	related	cancers,	diabetes,	coronary	heart	
disease,	stroke,	chronic	kidney	disease	and	osteoarthritis	(Australian	Institute	of	Health	
and	Welfare	2016).	If	the	rise	in	overweight	and	obesity	within	Australia	was	halted,	6%	
of	the	predicted	disease	burden	attributable	to	obesity–related	conditions	in	2020	could	
be	avoided.	Furthermore,	the	projected	disease	burden	in	2020	could	be	reduced	by	14%,	
if	 the	 body	 mass	 index	 (BMI)	 of	 at	 risk	 individuals	 was	 decreased	 by	 1	 kg/m2	
(approximately	3kg	weight	 loss	 for	 a	person	of	 average	height)	 (Australian	Burden	of	
Disease	Study	2017).		
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1.2	 Metabolic	syndrome	
Obesity	is	an	important	component	of	metabolic	syndrome,	a	combination	of	interrelated	
co–morbidities	that	substantially	increase	the	risk	of	developing	cardiovascular	disease,	
type	2	diabetes	and	non‐alcoholic	fatty	liver	disease	(NAFLD)	(Grundy	2016;	Sperling	et	
al.	2015).	Metabolic	 syndrome	 is	diagnosed	based	on	 the	presence	of	any	 three	of	 the	
following	criteria:	elevated	waist	circumference,	increased	plasma	triglycerides,	reduced	
high	density	lipoprotein	cholesterol	(HDL–c),	hypertension	and	fasting	hyperglycaemia	
(Table	1)	(Alberti	et	al.	2009).		
	
	
Table	1‐1.		Consensus	panel	diagnostic	criteria	for	metabolic	syndrome	
Any	three	of	the	following	criteria:	
Elevated	waist	circumference	
≥	94	cm	for	males	
≥	80	cm	for	females	
Note:	these	definitions	may	vary	between	populations	
Elevated	plasma	triglycerides	 ≥	150	mg/dL	(1.7	mmol/L)	or	drug	treatment	
Reduced	high–density	lipoprotein	
cholesterol	(HDL–c)	
<	40	mg/dL	(1.0	mmol/L)	for	males	
<	50	mg/dL	(1.3	mmol/L)	for	females	
or	drug	treatment	
Elevated	blood	pressure	
≥	130	mmHg	systolic		
and/or	≥	85	mmHg	diastolic		
or	drug	treatment	
Elevated	fasting	glucose	 ≥	100	mg/dL	or	drug	treatment	
Note:	The	consensus	panel	is	a	collaboration	between	the	International	Diabetes	Federation;	National	
Heart,	Lung	and	Blood	 Institute;	American	Heart	Association;	World	Heart	Federation;	 International	
Atherosclerosis	Society	and	International	Association	for	the	Study	of	Obesity	(Alberti	et	al.	2009).	
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The	key	traits	that	link	metabolic	syndrome	to	cardiovascular	disease,	type	2	diabetes	and	
NAFLD	 are	 increased	 visceral	 adiposity,	 dyslipidaemia,	 hypertension	 and	 insulin	
resistance	(Ballestri	et	al.	2016;	Bastien	et	al.	2014;	Lu	et	al.	2014b).	Dyslipidaemia	is	an	
abnormal	concentration	of	plasma	lipids,	including	elevated	LDL–c,	reduced	HDL–c	and	
increased	triglycerides.	Dyslipidaemia	and	hypertension	are	both	major	risk	factors	for	
myocardial	infarction	and	stroke,	potentially	fatal	cardiovascular	diseases	that	occur	due	
to	 the	 restriction	 of	 blood	 flow	 to	 the	 heart	 and	 brain,	 respectively	 (Lu	 et	 al.	 2014b).	
Elevated	 fasting	 blood	 glucose	 is	 indicative	 of	 insulin	 resistance,	 which	 results	 from	
impaired	 insulin	 receptor	 signalling	 and	 has	 an	 important	 role	 in	 the	 development	 of	
diabetes	and	NAFLD	(Mitsuhashi	et	al.	2017;	Ortiz‐Lopez	et	al.	2012).	
	
1.3	 Obesity	and	metabolic	syndrome	pathophysiology	
When	 energy	 intake	 exceeds	 energy	 expenditure,	 surplus	 nutrients	 are	 stored	 for	 use	
during	 times	of	 scarce	 food	 availability.	Unused	 glucose	 is	 stored	within	 the	 liver	 and	
skeletal	muscles	as	the	branched	polysaccharide	glycogen.	Once	the	glycogen	stores	are	
replenished,	the	remaining	glucose	is	converted	to	lipids	within	the	liver	via	the	process	
of	 de	 novo	 lipogenesis	 (Lu	 et	 al.	 2014a).	 Dietary	 and	 synthesised	 free	 fatty	 acids	 are	
transported	 through	 the	 bloodstream	 within	 lipoproteins,	 which	 vary	 in	 density	
depending	 on	 the	 ratio	 of	 lipids	within	 the	 hydrophobic	 core	 and	 proteins	within	 the	
amphiphilic	 outer	 membrane.	 LDL–c	 has	 a	 higher	 proportion	 of	 lipids	 compared	 to	
proteins,	whereas	HDL–c	has	a	greater	protein	content	and	transports	cholesterol	from	
peripheral	tissues	to	the	liver	(Griffin	2013;	Morgantini	et	al.	2014).		
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Circulating	 lipoproteins	are	degraded	by	endothelial	 lipoprotein	 lipases,	 releasing	 free	
fatty	 acids	 that	 surrounding	 cells	 break	 down	 and	 use	 for	 energy	 production	 (Griffin	
2013).	 Excess	 free	 fatty	 acids	 are	 converted	 to	 triglycerides	 and	 stored	 within	 white	
adipocytes,	the	only	cell	type	that	is	adapted	to	store	lipids	without	impairing	function	
(Hajer,	 van	Haeften	&	 Visseren	 2008).	 Chronic	 consumption	 of	 a	 diet	 rich	 in	 fats	 and	
simple	carbohydrates	increases	lipid	deposition	within	white	adipocytes	and	promotes	
adipose	 tissue	 expansion	 (Hoffstedt	 et	 al.	 2010).	 Metabolically	 healthy	 adipose	 tissue	
expands	 via	 hyperplasia,	 which	 involves	 stimulating	 the	 maturation	 of	 adipocyte	
precursors	to	increase	cell	numbers,	whereas	the	metabolic	dysfunction	associated	with	
obesity	also	causes	adipocytes	to	expand	via	hypertrophy,	which	increases	the	cell	size	
(Figure	1–1)	(Rydén	et	al.	2014;	Shao	et	al.	2018).	Adipocyte	hypertrophy	is	detrimental	
for	 cell	 function,	 as	 excessive	 lipid	 accumulation	 induces	 toxic	 effects	 (Hoffstedt	 et	 al.	
2010;	Muir	et	al.	2018).	
	
Adipose	 tissue	expansion	 is	accompanied	by	angiogenesis,	 the	 formation	of	new	blood	
vessels,	as	 the	 larger	 tissue	mass	requires	an	additional	supply	of	blood	and	nutrients	
(Gealekman	et	al.	2011).	When	adipose	 tissue	expansion	occurs	more	rapidly	 than	the	
rate	of	angiogenesis,	blood	supply	to	the	tissue	is	diminished	and	the	adipocytes	become	
hypoxic	due	to	insufficient	oxygen	availability	(Pasarica	et	al.	2009).	Adipocytes	that	incur	
irreparable	 damage	 due	 to	 hypoxia	 undergo	 necrotic	 cell	 death,	which	 stimulates	 the	
infiltration	 of	 macrophages	 that	 surround	 dying	 adipocytes	 and	 form	 “crown–like”	
histological	 structures	 (Murano	 et	 al.	 2008).	 The	 macrophages	 within	 obese	 adipose	
tissue	 tend	 to	have	an	 inflammation–promoting	M1	phenotype,	whereas	metabolically	
healthy	 adipose	 tissue	 contains	 a	 greater	 proportion	 of	 anti–inflammatory	 M2	
macrophages	(Muir	et	al.	2018).		
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White	 adipose	 tissue	 is	 not	merely	 a	 storage	 site	 for	 excess	 fatty	 acids,	 but	 is	 also	 an	
essential	endocrine	organ	involved	in	regulating	satiety,	metabolism	and	inflammation.	
These	effects	are	mediated	by	adipokines,	the	bioactive	proteins	produced	by	adipocytes	
and	 adipose	 tissue	 macrophages.	 The	 adipokine–dependent	 regulation	 of	 satiety	 is	
primarily	facilitated	by	leptin,	which	targets	the	hypothalamus	to	suppress	appetite	and	
reduce	food	intake	(Ouchi	et	al.	2011).	Although	leptin	secretion	increases	in	proportion	
to	adipose	tissue	mass,	obese	individuals	can	become	resistant	to	the	anorexigenic	effects	
of	 leptin.	Leptin	resistance	 is	attributed	to	reduced	 leptin	availability	within	 the	brain,	
Figure	1‐1.	Comparison	of	metabolically	healthy	adipose	tissue	expansion	and	the
dysfunctional	adipose	tissue	expansion	associated	with	obesity	
a)	Metabolically	healthy	adipose	tissue	expansion	involves	the	maturation	of	preadipocytes	to
increase	cell	numbers,	formation	of	new	blood	vessels	to	provide	an	adequate	nutrient	supply
and	an	increase	in	anti–inflammatory	M2	adipose	tissue	macrophages	(ATMs)	and	regulatory	T	
cells	(Tregs).	b)	Obese	adipose	tissue	expands	via	an	increase	in	adipocyte	size,	which	increases
cell	stress	and	promotes	the	infiltration	of	pro–inflammatory	M1	ATMs	and	natural	killer	(NK)	
cells.	 Adipogenesis	 is	 also	 impaired	 by	 unhealthy	 adipose	 tissue	 expansion,	 which	 leads	 to
hypoxia	and	necrotic	cell	death	(Kusminski,	Bickel	&	Scherer	2016,	p.	645).	
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resulting	from	diminished	passage	across	the	blood–brain	barrier,	and	impaired	 leptin	
receptor	signalling	(Myers	Jr	et	al.	2010).		
	
Adipokine	production	is	dysregulated	in	metabolically	unhealthy	adipose	tissue,	inducing	
a	 state	 of	 chronic	 low–grade	 inflammation.	 Increased	 secretion	 of	 pro–inflammatory	
adipokines,	 including	 leptin,	 tumour	 necrosis	 factor–alpha	 (TNF–α)	 and	 interleukin–6	
(IL–6),	during	obesity	contributes	to	the	development	of	metabolic	dysfunction,	insulin	
resistance	and	cardiovascular	disease	(Ouchi	et	al.	2011).	This	systemic	inflammation	is	
further	 enhanced	 by	 the	 decreased	 production	 of	 adiponectin,	 an	 anti–inflammatory	
adipokine	that	improves	insulin	sensitivity,	reduces	metabolic	syndrome	risk	factors	and	
is	protective	against	cardiovascular	disease	(Ohashi	et	al.	2014).		
	
Adipokine	expression	also	varies	depending	on	the	location	of	adipose	tissue	deposition.	
Although	subcutaneous	adipose	tissue	is	the	largest	deposit	within	the	body,	the	risk	of	
developing	metabolic	syndrome	is	substantially	higher	among	individuals	with	increased	
abdominal	adiposity.	This	is	due	to	the	proximity	between	intra–abdominal	adipose	tissue	
and	 the	 visceral	 organs,	which	 allows	 adipokines	 to	 strongly	 influence	 cardiovascular,	
pancreatic	and	liver	function	(Samaras	et	al.	2010).	
	
1.3.1	 Cardiovascular	disease	
Obesity	doubles	the	risk	of	developing	heart	failure,	which	is	attributed	to	an	increase	in	
cardiac	output	and	the	expansion	of	blood	volume	in	proportion	to	body	mass	(Kenchaiah	
et	al.	2002;	Reddy	et	al.	2016).	Over	time,	this	heightened	cardiac	workload	induces	left	
ventricular	hypertrophy,	a	condition	that	occurs	when	the	muscle	wall	of	the	left	ventricle	
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thickens	and	loses	elasticity	(Figure	1–2)	(Mahajan,	Lau	&	Sanders	2015).	The	reduced	
ventricular	wall	compliance	leads	to	diastolic	dysfunction,	which	may	further	progress	to	
systolic	dysfunction	and	high–output	heart	failure	(Alpert	et	al.	2014;	Bastien	et	al.	2014).	
Cardiac	 remodelling	 is	 most	 prominent	 among	 severely	 obese	 individuals	 and	 in	 the	
presence	 of	 obesity–related	 co–morbidities	 that	 are	 also	 independent	 risk	 factors	 for	
heart	failure,	including	hypertension,	obstructive	sleep	apnoea,	coronary	artery	disease	
and	diabetes	(Aurigemma,	de	Simone	&	Fitzgibbons	2013;	Pujante	et	al.	2013;	Reis	et	al.	
2014).		
	
	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1‐2.	Structural	remodelling	of	the	heart	due	to	obesity	
Obesity	is	associated	with	multiple	factors,	such	as	hypertension,	increased	epicardial	fat	and
obstructive	 sleep	 apnoea	 (OSA),	 that	 place	 additional	 burden	 on	 the	 heart.	 Left	 ventricular
hypertrophy,	which	 is	characterised	by	an	 increase	 in	 left	ventricular	mass	and	relative	wall
thickness	(RWT),	occurs	as	a	result	of	the	increased	cardiac	workload	and	causes	a	decrease	in	
ventricular	filling	rate	during	diastole.	Obesity	has	also	been	attributed	to	left	atrial	enlargement
(Aurigemma,	de	Simone	&	Fitzgibbons	2013,	p.	148).	
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1.4	 Current	obesity	treatments	and	limitations	
 Obesity–related	 co–morbidities	 currently	 cost	 the	 Australian	 economy	 $8.6	 billion	
dollars	
 Drug	 interventions	 can	 be	 used	 in	 conjunction	 with	 diet	 changes	 and	 exercise,	
although	often	have	unpleasant	side	effects.	E.g.	orlistat,	a	gastric	lipase	inhibitor,	is	
associated	 with	 abdominal	 pain,	 faecal	 urgency	 and	 loose,	 oily	 stools.	 Three	 anti‐
obesity	drugs	have	also	been	withdrawn	from	the	market	in	the	past	decade	due	to	
serious	adverse	events:	rimonabant	failed	FDA	approval	in	the	US	and	was	withdrawn	
from	 European	 market	 in	 2009	 due	 to	 concerning	 psychiatric	 effects,	 benfluorex	
(available	 in	Europe	only)	was	withdrawn	 in	2009	due	 to	potentially	 fatal	valvular	
heart	disease	and	sibutramine,	which	was	withdrawn	in	multiple	countries	in	2010	
due	to	increased	risk	of	myocardial	infarction	and	stroke	in	predisposed	patients.	
 Bariatric	surgery	is	currently	the	most	effective	long‐term	treatment,	although	may	
not	be	a	viable	option	in	all	cases	due	to	the	risk	of	surgical	complications.	
 Dietary	interventions	and	exercise	are	highly	effective	methods	for	weight	 loss	and	
improving	 overall	 health,	 although	 have	 limited	 long‐term	 efficacy	 due	 to	 poor	
compliance.	Weight	regain	is	also	common,	which	is	potentially	due	to	a	prolonged	
decrease	in	metabolic	rate	after	weight	loss		(Fothergill	et	al.	2016).	
 Thus,	 there	 is	 an	 urgent	 need	 for	 safer	 and	 more	 effective	 obesity	 treatments.	
Understanding	 the	 physiological	 mechanisms	 involved	 in	 the	 dietary	 reversal	 of	
obesity	could	provide	potential	targets	to	improve	long‐term	weight	loss	efficacy.	
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1.5	 Dietary	interventions	in	the	reversal	of	metabolic	syndrome	
 Discuss	 previous	 approaches	 to	 changing	 diet	 for	 reversal	 of	 metabolic	 syndrome	
(include	how	these	benefit	patients	that	have	been	diagnosed	with	type	2	diabetes,	
atherogenic	dyslipidaemia,	hypertension	and	NAFLD)	
 Calorie	restriction,	intermittent	fasting,	functional	foods	and	supplements	
 Calorie	restriction	is	the	reduction	of	energy	intake	without	resulting	in	malnutrition	
 Importance	of	macronutrients	–	are	low‐protein,	‐carbohydrate	or	‐fat	diets	the	most	
effective?	
	
1.6	 Project	aims	and	hypotheses	
This	study	aims	to	determine:	
 If	switching	from	a	diet	that	is	rich	in	simple	carbohydrates	and	saturated	fats	to	a	
healthier	diet	can	reverse	the	symptoms	of	diet–induced	metabolic	syndrome.	
 The	sequence	of	metabolic,	 cardiovascular	and	hepatic	 changes	 that	occur	over	
time	after	switching	to	a	healthier	diet.	
	
It	is	hypothesised	that:	
 Consumption	of	a	high–carbohydrate,	high–fat	diet	will	induce	signs	of	metabolic	
syndrome,	which	will	be	reversed	after	switching	to	a	diet	that	is	low	in	fat,	high	in	
complex	carbohydrates	and	less	energy	dense.	
 Switching	to	a	healthier	diet	will	progressively	improve	metabolic,	cardiovascular	
and	hepatic	function.	
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Chapter	2. 	 Methods	and	materials	
2.1	 Rats,	experimental	groups	and	housing	
All	 experimental	 protocols	were	 approved	 by	 the	 University	 of	 Southern	 Queensland	
Animal	 Ethics	 Committee	 (Project	 number	 –	 17REA003)	 under	 the	 guidelines	 of	 the	
National	 Health	 and	Medical	 Research	 Council	 of	 Australia.	 For	 this	 project,	 84	male	
Wistar	rats	(8–9	weeks	old,	335	±	5	g)	were	purchased	from	the	Animal	Resource	Centre,	
Murdoch,	WA,	Australia.	After	arrival,	rats	were	fed	a	standard	laboratory	chow	diet	and	
given	approximately	one	week	 to	acclimatise.	Rats	were	 then	randomly	allocated	 into	
seven	experimental	groups	(n	=	12	rats/group):	
	
1. C	–	rats	received	a	corn	starch	(CS)	diet	for	16	weeks	
2. H	–	rats	received	a	high–carbohydrate,	high–fat	(HCHF)	diet	for	16	weeks	
3. H8	–	rats	received	HCHF	diet	for	8	weeks	
4. H8C1	–	rats	received	HCHF	diet	for	8	weeks,	then	CS	diet	for	week	9	of	protocol	
5. H8C2	–	rats	received	HCHF	diet	for	8	weeks,	then	CS	diet	for	weeks	9–10	of	protocol	
6. H8C4	–	rats	received	HCHF	diet	for	8	weeks,	then	CS	diet	for	weeks	9–12	of	protocol	
7. H8C8	–	rats	received	HCHF	diet	for	8	weeks,	then	CS	diet	for	weeks	9–16	of	protocol	
	
The	 experimental	 protocol	 is	 outlined	 in	 Figure	 2–1.	 All	 rats	were	 housed	within	 the	
animal	 facility	 at	 the	 University	 of	 Southern	 Queensland	 Toowoomba	 campus,	 in	 a	
temperature‐controlled	(21	±	2°C)	room	with	an	automated	12‐hour	light	and	dark	cycle.	
The	rats	were	provided	individual	cages	and	ad	libitum	access	to	food	and	water.		
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2.2	 Materials	
Beef	 tallow	was	purchased	 from	Carey	Brothers,	Warwick,	QLD,	Australia.	Condensed	
milk	was	purchased	from	Coles	Kearneys	Spring,	Toowoomba,	QLD,	Australia.	Meat‐free	
powdered	 rat	 food	was	 purchased	 from	 Specialty	 Feeds,	 Glen	 Forrest,	WA,	 Australia.	
Hubble,	Mendel	and	Wakeman	salt	mixture	was	purchased	from	MP	Biomedicals,	Seven	
Hills,	NSW,	Australia.	Fructose	was	purchased	from	Tate	&	Lyle,	Wacol,	QLD,	Australia.	
Corn	 starch	 was	 purchased	 from	 Agri	 Food	 Ingredients,	 Kew	 East,	 VIC,	 Australia.	 All	
laboratory	 chemicals	were	 purchased	 from	 Sigma‐Aldrich	 Australia,	 Castle	 Hill,	 NSW,	
Australia,	unless	otherwise	specified.	
	
Figure	2‐1.	Timeline	of	the	experimental	protocol	
CS,	corn	starch	diet;	HCHF,	high‐carbohydrate,	high‐fat	diet;	C,	rats	fed	CS	diet	for	16	weeks;	H,	rats	
fed	HCHF	diet	for	16	weeks;	H8,	rats	fed	HCHF	diet	for	8	weeks;	H8C1,	rats	fed	HCHF	diet	for	8	weeks	
then	switched	to	CS	diet	for	1	week;	H8C2,	rats	fed	HCHF	diet	for	8	weeks	then	switched	to	CS	diet	for	
2	weeks;	H8C4,	rats	fed	HCHF	diet	for	8	weeks	then	switched	to	CS	diet	for	4	weeks;	H8C8,	rats	fed	
HCHF	diet	for	8	weeks	then	switched	to	CS	diet	for	8	weeks;	OGTT,	oral	glucose	tolerance	test;	DEXA,	
dual‐energy	x‐ray	absorptiometry;	SBP,	systolic	blood	pressure.	
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Blood	pressure 
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Langendorff 
Biochemical	analyses 
Tissue	histology 
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(HCHF	diet	for	H	only) 
HCHF	diet	 
(CS	diet	for	C	only) 
C,	H,	H8C8
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Blood	pressure 
Oxymax
H8 H8C1 H8C2 H8C4 C,	H,	H8C8 
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2.3	 Diets	
All	diets	were	prepared	at	the	University	of	Southern	Queensland	animal	house	facility.	
The	CS	diet	comprised	570g	corn	starch,	155g	powdered	rat	food,	25g	Hubble,	Mendel	
and	 Wakeman	 salt	 mixture	 and	 250mL	 water	 per	 kilogram	 of	 food.	 The	 HCHF	 diet	
contained	 175g	 fructose,	 395g	 sweetened	 condensed	 milk,	 200g	 beef	 tallow,	 155g	
powdered	rat	food,	25g	Hubble,	Mendel	and	Wakeman	salt	mixture	and	50mL	water	per	
kilogram	of	food.	Rats	fed	the	CS	diet	were	provided	with	normal	drinking	water,	while	
the	HCHF	diet	included	drinking	water	supplemented	with	25%	fructose	(w/v).	Energy	
intake	was	calculated	from	the	following	values	in	kilojoules	per	gram:	corn	starch,	15.94;	
powdered	rat	food,	13.80;	fructose,	15.40;	condensed	milk,	13.80	and	beef	tallow,	37.70.	
The	energy	density	of	the	CS	diet	was	11.23	kJ/g	and	HCHF	diet	was	17.83	kJ/g	with	an	
additional	3.85	kJ/mL	of	drinking	water.	
	
Table	2‐1.	Composition	of	the	CS	and	HCHF	diets	
Components	(g/kg)	 CS	diet	 HCHF	diet	
Corn	starch	 570	g	 –	
Fructose	 –	 175	g	
Condensed	milk	 –	 395	g	
Beef	tallow	 –	 200	g	
Salt	mixture	 25	g	 25	g	
Powdered	rat	food	 155	g	 155	g	
Water	 250	mL	 50	mL	
Drinking	water	 No	additives	 25%	fructose	(w/v)	
CS,	corn	starch	diet;	HCHF,	high‐carbohydrate,	high‐fat	diet.	
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2.4	 Daily	measurements	
The	body	weight,	water	 intake	and	food	consumption	of	each	rat	was	measured	daily.	
Overall	health	was	monitored	each	day	and	the	cage	bedding	was	changed	on	a	regular	
basis.	Energy	intake	was	calculated	from	the	energy	densities	of	the	CS	and	HCHF	diets.	
Feed	efficiency	was	calculated	using	the	following	formula:	
	
Feed	conversion	efficiency	ൌ	mean	body	weight	gain	ሺgሻdaily	energy	intake	ሺkJሻ 	
	
	
2.5	 Body	composition	measurement	
Dual–energy	x–ray	absorptiometry	(DEXA)	was	performed	using	a	Norland	XR‐46	DEXA	
densitometer	(Norland	Corporation,	Fort	Atkinson,	WI,	USA)	at	the	beginning	and	end	of	
protocol.	An	additional	DEXA	scan	was	performed	for	C,	H	and	H8C8	rats	at	week	8	of	
protocol.	Rats	were	anaesthetised	via	an	intraperitoneal	injection	of	Zoletil	(tiletamine	
10	mg/kg	and	zolazepam	10	mg/kg;	Virbac,	Peakhurst,	NSW,	Australia).	Lean	mass,	fat	
mass,	 bone	 mineral	 content	 and	 bone	 mineral	 density	 were	 analysed	 using	 the	
manufacturer’s	 recommended	 software	 for	 use	 in	 laboratory	 animals	 (Small	 Subject	
Analysis	Software,	version	4.5.0/2.3.1,	Norland	Corp.)	(Panchal	et	al.	2011).	Whilst	the	
rats	were	still	sedated,	abdominal	circumference	was	measured	in	the	ventral	recumbent	
position	using	a	standard	measuring	tape	(Panchal	et	al.	2011).	
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2.6	 Oral	glucose	tolerance	test	
An	oral	glucose	tolerance	test	(OGTT)	was	performed	before	commencing	and	at	the	end	
of	protocol.	Rats	were	food‐deprived	for	12	hours	and	fructose–supplemented	water	was	
replaced	with	normal	drinking	water.	After	the	overnight	 fast,	 the	basal	blood	glucose	
concentration	in	tail	vein	blood	was	measured	using	a	FreeStyle	Lite	blood	glucose	test	
strip	 (Abbott	 Diabetes	 Care	 Inc.,	 Doncaster,	 VIC,	 Australia)	 attached	 to	 a	 FreeStyle	
Freedom	Lite	 glucometer	 (Abbott	Diabetes	 Care	 Inc.).	 Rats	were	 administered	 a	 40%	
aqueous	glucose	solution	(2g	glucose/kg	body	weight)	via	oral	gavage.	Tail	vein	blood	
samples	were	taken	at	30,	60,	90	and	120	minutes	after	glucose	administration	(Panchal	
et	 al.	 2011).	 After	 recording	 the	 120‐minute	 blood	 glucose	 concentrations,	 rats	were	
returned	to	their	group‐specific	diet	and	water.	The	area	under	the	curve	was	calculated	
from	the	graph	of	blood	glucose	concentrations	over	time.	
	
2.7	 Calorimetry	
Indirect	calorimetry	was	performed	using	an	Oxymax	system	(Columbus	 Instruments,	
Columbus,	USA)	at	8	weeks	for	C,	H	and	H8C8	rats	and	for	all	groups	prior	to	termination.	
The	system	was	calibrated	using	special	purpose	gas	comprising	78.7%	nitrogen,	20.8%	
oxygen	and	0.5%	carbon	dioxide.	Rats	were	weighed	and	placed	into	individual	metabolic	
cages	and	metabolic	readings	were	measured	for	12	hours	during	the	dark	cycle.	Food	
and	water	 intakes	were	 recorded	and	 rats	were	 returned	 to	 their	normal	 cages.	Heat	
production	 and	 respiratory	 exchange	 ratio	 (RER)	 were	 calculated	 as	 outlined	 in	 the	
manufacturer’s	instructions	(Sekar	et	al.	2017).	
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2.8	 Systolic	blood	pressure	measurement	
Systolic	 blood	 pressure	was	measured	 at	 the	 beginning	 and	 end	 of	 protocol,	 with	 an	
additional	measurement	performed	for	C,	H	and	H8C8	rats	at	week	8,	using	a	MLT844	
Physiological	Pressure	Transducer	(ADInstruments,	Sydney,	NSW,	Australia)	connected	
to	 a	 PowerLab	 data	 acquisition	 unit	 (ADInstruments).	 Rats	were	 anaesthetised	 using	
Zoletil	 (tiletamine	 10	 mg/kg	 and	 zolazepam	 10	 mg/kg,	 Virbac)	 administered	 via	
intraperitoneal	injection.	After	calibrating	the	blood	pressure	machine,	an	inflatable	tail	
cuff	was	positioned	at	the	base	of	the	tail	and	a	MLT1010	Piezo–Electric	Pulse	Transducer	
(ADInstruments)	was	placed	immediately	posterior	to	the	tail	cuff.	When	a	stable	pulse	
was	 detected,	 occlusion	 was	 initiated	 and	 five	 to	 six	 blood	 pressure	 readings	 were	
recorded	for	each	rat	using	LabChart	Pro	(ADInstruments)	(Panchal	et	al.	2011).	
	
2.9	 Euthanasia	and	Langendorff	heart	preparation	
At	the	end	of	protocol,	rats	were	euthanised	via	intraperitoneal	 injection	of	Lethabarb	
(pentobarbitone	 sodium,	 100	 mg/kg,	 Virbac).	 Immediately	 after	 euthanasia,	 heparin	
(200	IU)	was	injected	into	the	right	femoral	vein	and	approximately	6mL	of	abdominal	
aorta	blood	was	collected	into	heparinised	tubes.	Plasma	was	obtained	by	centrifuging	
the	blood	at	5000× g	for	10	minutes	and	stored	at	‐20°C	until	biochemical	analysis	was	
performed.	For	Langendorff	heart	preparation,	 the	 isolated	hearts	were	perfused	with	
modified	 Krebs–Henseleit	 bicarbonate	 buffer,	 which	 consisted	 of	 (in	 mmol/L):	 119.1	
NaCl,	4.75	KCl,	1.19	MgSO4,	1.19	KH2PO4,	25.0	NaHCO3,	11.0	glucose	and	2.16	CaCl2.	The	
buffer	was	bubbled	with	95%	O2–5%	CO2	and	maintained	at	35°C.	A	latex	balloon	catheter	
was	 inserted	 into	 the	 left	 ventricle	 and	 the	 isovolumetric	 ventricular	 function	 was	
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measured	using	a	Capto	SP844	MLT844	physiological	pressure	transducer	and	Maclab	
Chart	software	(ADInstruments).	An	electrical	stimulator	was	used	to	pace	the	heart	at	
250	beats/minute	and	left	ventricular	end–diastolic	pressure	values	were	obtained	from	
0	to	30	mmHg	to	calculate	the	diastolic	stiffness	constant	(κ,	dimensionless)	(Panchal	et	
al.	2011).	
	
2.10	 Organ	weights	
After	the	isolated	Langendorff	heart	preparation,	the	right	ventricle	was	separated	from	
the	left	ventricle	and	septum	for	weighing.	The	liver,	abdominal	fat,	spleen,	kidneys	and	
brown	fat	were	removed	and	weighed.	Organ	weights	were	standardised	in	relation	to	
tibial	length	(mg	tissue/mm	tibial	length)	(Panchal	et	al.	2011).	Visceral	adiposity	index	
was	calculated	using	the	formula:	
Visceral	adiposity	index	ሺ%ሻ	=	 retroperitoneal	fat	ሺgሻ	+	omental	fat	ሺgሻ	+	epididymal	fat	ሺgሻbody	weight	ሺgሻ 	×100	
	
2.11	 Histology	
The	heart	and	liver	from	four	rats	in	each	group	were	isolated	and	fixed	in	10%	neutral	
buffered	 formalin.	 After	 three	 days,	 the	 samples	 were	 processed	 and	 embedded	 in	
paraffin	wax.	Thin	sections,	5	µm	in	size,	were	cut	and	stained	with	haematoxylin	and	
eosin	 for	 determination	 of	 inflammatory	 cell	 infiltration	 (20×)	 and	 liver	 fat	 vacuole	
presence	(20×)	(Panchal	et	al.	2011).	Two	slides	were	prepared	per	tissue	specimen	and	
two	 random,	 non–overlapping	 fields	were	 taken	 per	 slide	 to	 prevent	 biased	 analysis.	
Images	of	these	slides	were	captured	using	an	EVOS	FLC	microscope.	
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2.12	 Biochemical	analyses	
Plasma	samples	collected	during	the	terminal	experiments	were	analysed	to	determine	
the	 concentrations	 of	 lipids	 and	 liver	 damage	 biomarkers.	 Plasma	 total	 cholesterol,	
triglycerides,	 non–esterified	 fatty	 acids	 and	 activities	 of	 the	 liver	 enzymes	 alanine	
transaminase	and	aspartate	 transaminase	were	determined	using	kits	and	controls	as	
described	previously	(Panchal	et	al.	2011).	
	
2.13	 Statistical	analysis	
All	data	are	presented	as	mean	±	standard	error	of	the	mean	(SEM).	Variances	within	the	
data	were	detected	using	Bartlett’s	test.	The	effects	of	changing	diet	were	evaluated	using	
one–way	analysis	of	variance	and	the	Newman–Keuls	multiple	comparison	post	hoc	test.	
Student’s	t–test	was	used	to	compare	body	weight,	energy	intake	and	feed	efficiency	in	
H8C1,	H8C2,	H8C4	and	H8C8	groups	before	(0–8	weeks)	and	after	switching	to	the	corn	
starch	diet.	All	statistical	analyses	were	performed	using	Prism	version	5.00	for	Windows	
(GraphPad	 Software,	 San	 Diego,	 CA,	 USA)	 and	 a	 P–value	 of	 <0.05	 was	 considered	
statistically	significant.	
	
18	
Chapter	3. 	 Results	
3.1	 Physiological	variables	
Initially,	the	body	weights	were	similar	across	all	groups	of	rats	(Figure	3–1).	Throughout	
the	16–week	protocol,	the	C	rats	had	significantly	lower	body	weights	in	comparison	to	
the	H	and	H8C8	rats	(P	<	0.0001)	(Figure	3–1A).	Despite	having	similar	body	weights	at	
8	weeks,	the	H8C8	rats	had	significantly	lower	body	weights	at	16	weeks	compared	to	the	
H	rats	(P	<	0.0001).	Although	the	H8C1,	H8C2	and	H8C4	groups	had	higher	body	weights	
than	 the	 H8	 and	 H8C8	 groups	 at	 8	 weeks,	 these	 differences	 were	 not	 statistically	
significant	(P	=	0.08)	(Figure	3–1B).	Weight	loss	after	the	diet	switch	followed	a	similar	
trend	across	all	groups,	however	the	H8C8	group	began	to	regain	weight	at	week	12	and	
exceeded	the	body	weight	at	week	8	within	6	weeks	of	changing	diet.		
	
Daily	food	intake	was	significantly	greater	for	the	C	rats	in	comparison	to	the	H	rats	(P	<	
0.0001)	(Figure	3–1C).	Despite	having	a	similar	food	intake	to	the	H	rats	during	the	first	
8	weeks,	food	intake	rapidly	increased	for	the	H8C8	rats	after	the	diet	switch	and	was	
similar	to	the	C	rats	throughout	the	final	8	weeks	of	protocol.	Daily	food	intake	during	
weeks	0–8	was	similar	 for	 the	H8,	H8C1	and	H8C4	rats,	whereas	 the	H8C2	rats	had	a	
significantly	greater	food	intake	and	the	H8C8	rats	had	a	significantly	lower	food	intake	
in	comparison	to	these	three	groups	(P	=	0.04)	(Figure	3–1D).	Food	intake	consistently	
increased	for	all	rats	after	switching	to	the	CS	diet	(P	<	0.05),	although	the	H8C1	group	
consumed	significantly	 less	 food	than	the	H8C2,	H8C4	and	H8C8	groups	after	 the	diet	
switch	(P	<	0.0001).		
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Despite	the	increased	food	intake,	daily	energy	intake	was	significantly	lower	for	the	C	
rats	in	comparison	to	the	H	rats	(P	<	0.001)	(Figure	3–1E).	Daily	energy	intake	before	the	
diet	switch	was	similar	for	the	H8,	H8C1	and	H8C2	groups,	although	the	H8C2	rats	had	a	
significantly	 greater	 energy	 intake	 compared	 to	 the	H8C4	 and	H8C8	 rats	 (P	 =	 0.003)	
(Figure	3–1F).	After	changing	diet,	the	H8C1	group	had	a	significantly	lower	energy	intake	
in	comparison	to	the	H8C2,	H8C4	and	H8C8	groups	(P	<	0.0001).	Energy	intake	was	also	
significantly	lower	for	the	H8C2	rats	after	the	diet	switch	in	comparison	to	the	H8C4	rats.	
The	daily	energy	intake	for	each	group	significantly	decreased	after	switching	to	the	CS	
diet,	with	a	41%	reduction	for	the	H8C1	rats,	34%	for	the	H8C2	rats,	14%	for	the	H8C4	
and	19%	for	the	H8C8	rats	compared	to	the	energy	intake	during	the	first	8	weeks	(P	<	
0.05).	
	
Daily	water	intake	for	the	C	rats	was	significantly	higher	over	the	first	8	weeks	of	protocol	
in	comparison	to	the	H	and	H8C8	groups	provided	with	fructose–supplemented	drinking	
water	(P	=	0.01)	(Table	3–1).	During	weeks	8–16,	the	daily	water	intake	increased	for	the	
H	 and	 H8C8	 rats	 and	 was	 similar	 to	 the	 C	 group.	 Food	 conversion	 efficiency	 was	
significantly	 greater	 for	 the	H	 and	H8C8	 groups	 than	 the	C	 group	during	 the	 initial	 8	
weeks	(P	<	0.0001).	Despite	a	decrease	after	week	8,	the	food	conversion	efficiency	of	the	
H	group	remained	higher	than	the	C	group	at	16	weeks.		Although	the	H8C8	rats	had	a	
similar	food	conversion	efficiency	to	the	H	rats	during	the	first	8	weeks,	this	decreased	
substantially	after	the	diet	switch	and	was	lower	than	the	C	rats	during	weeks	8–16	(P	<	
0.0001).	
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Figure	3‐1.		Effects	of	switching	diet	on	body	weight,	food	intake	and	energy	intake	at	
16	weeks	(A,	C,	E)	and	at	varying	time	points	(B,	E,	F).		
Values	are	mean	±	SEM,	n	=	10–12.	Means	with	an	uncommon	letter	differ	significantly	(P	<	0.05).	
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	H8,	
rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	
for	8	weeks	then	switched	to	a	corn	starch	diet	for	1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐fat	
diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	high‐
fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;	H8C8,	rats	fed	a	high‐carbohydrate,	
high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks.	
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The	H8C8	rats	had	a	significantly	lower	water	intake	compared	to	the	H8,	H8C1,	H8C2	
and	H8C4	groups	during	the	first	8	weeks	of	protocol	(P	=	0.01),	although	all	groups	had	
a	similar	water	intake	after	the	diet	switch	(Table	3–2).	Food	conversion	efficiency	during	
weeks	0–8	was	similar	for	the	H8C1,	H8C2	and	H8C4	rats,	although	the	H8	and	H8C1	rats	
had	a	significantly	lower	food	conversion	efficiency	compared	the	H8C4	rats	(P	=	0.01).	
After	 the	 diet	 switch,	 the	 food	 conversion	 efficiency	 significantly	 decreased	 for	 each	
group	and	the	H8C8	group	had	a	greater	food	conversion	efficiency	in	comparison	to	the	
H8C1,	H8C2	and	H8C4	groups	(P	<	0.0001).		
Table	3‐1.		Body	weight,	energy	intake	and	feed	efficiency	at	16	weeks	
Variable	 C	 H	 H8C8	 P–value	
Initial	body	weight	(g)	 338	±	1	 341	±	1	 338	±	1	 0.0620	
Body	weight	at	8	weeks	(g)	 373	±	5	a	 444	±	6	b	 431	±	8	b	 <	0.0001	
Final	body	weight	(g)	 408	±	6	a	 512	±	6	b	 444	±	9	c	 <	0.0001	
Water	intake	0‐8	weeks	
(mL/day)	 33.7	±	2.4	a	 25.8	±	1.6	b	 25.1	±	2.2	b	 0.0105	
Water	intake	8‐16	weeks	
(mL/day)	 32.1	±	2.3	 30.4	±	1.0	 30.6	±	2.4	 0.8003	
Food	intake	0‐8	weeks	
(g/day)	 42.7	±	1.0	a	 29.6	±	1.4	b	 26.6	±	1.0	b	 <	0.0001	
Food	intake	8‐16	weeks	
(g/day)	 41.7	±	1.1	a	 28.1	±	0.8	b	 40.8	±	1.0	a	 <	0.0001	
Energy	intake	0‐8	weeks	
(kJ/day)	 479	±	11	b	 626	±	31	a	 568	±	27	a	 0.0006	
Energy	intake	8‐16	weeks	
(kJ/day)	 469	±	13	b	 618	±	16	a	 460	±	9	b	 <	0.0001	
Food	conversion	efficiency		
0‐8	weeks	(g/kJ)	 0.073	±	0.011	b	 0.166	±	0.006	a	 0.164	±	0.012	a	 <	0.0001	
Food	conversion	efficiency		
8‐16	weeks	(g/kJ)	 0.077	±	0.006	
b	 0.111	±	0.004	a	 0.026	±	0.012	c	 <	0.0001	
Values	are	mean	±	SEM,	n	=	11‐12.	Means	in	a	row	with	unlike	superscripts	differ	(P	<	0.05).	
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	and	switched	to	a	corn	starch	diet	for	
an	additional	8	weeks.	
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Table	3‐2.		Time‐dependent	effects	of	switching	diet	on	body	weight,	food	intake	and	feed	efficiency	
Variable	 H8	 H8C1	 H8C2	 H8C4	 H8C8	 P–value	
Initial	body	weight	(g)	 340	±	1	 339	±	1	 341	±	1	 339	±	1	 338	±	1	 0.3063	
Body	weight	8	weeks	(g)	 439	±	6	 457	±	11	 461	±	9	 459	±	10	 431	±	8	 0.0824	
Final	body	weight	(g)	 439	±	6	 443	±	10	 441	±	7	 442	±	10	 444	±	9	 0.9953	
Water	intake	0‐8	weeks	(mL/day)	 33.3	±	0.9	a	 32.2	±	1.1	a	 31.5	±	1.1	a	 32.2	±	1.4	a	 25.1	±	2.2	b	 0.0011	
Water	intake	after	diet	switch	
(mL/day)	 N/A	 34.5	±	1.8	 33.3	±	1.1	 35.0	±	1.3	 30.6	±	2.4	 0.2949	
Food	intake	0‐8	weeks	(g/day)	 28.7	±	0.9	ab	 28.2	±	1.0	ab	 31.4	±	1.2	a	 30.1	±	1.4	ab	 26.6	±	1.0	b	 0.0369	
Food	intake	after	diet	switch	(g/day)	 N/A	 33.5	±	1.2	a*	 40.0	±	1.3	b*	 44.0	±	1.1	b*	 40.8	±	1.0	b*	 <	0.0001	
Energy	intake	0‐8	weeks	(kJ/day)	 646	±	15	ab	 633	±	19	ab	 683	±	24	a	 575	±	26	b	 568	±	27	b	 0.0030	
Energy	intake	after	diet	switch	(kJ/day)	 N/A	 376	±	13	c*	 450	±	15	b*	 495	±	12	a*	 460	±	9	ab*	 <	0.0001	
Food	conversion	efficiency	0‐8	weeks	
(g/kJ)	 0.153	±	0.010	b	 0.185	±	0.014	ab	 0.184	±	0.009	ab	 0.213	±	0.019	a	 0.164	±	0.012	b	 0.0122	
Food	conversion	efficiency	after	diet	
switch	(g/kJ)	 N/A	 ‐0.038	±	0.009	b* ‐0.054	±	0.012	b* ‐0.044	±	0.008	b* 0.026	±	0.012	a*	 <	0.0001	
Values	are	mean	±	SEM,	n	=	10‐12.	Means	in	a	row	with	unlike	superscripts	differ	(P	<	0.05).	*	indicates	a	significant	difference	within	a	group	after	the	diet	
switch.	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	
1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	high‐
fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;	H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	
diet	for	8	weeks.	
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3.2	 Body	composition	
Bone	mineral	density	did	not	significantly	differ	between	the	C,	H	and	H8C8	groups	(Table	
3–3).	The	H	rats	had	a	greater	bone	mineral	content	than	the	C	and	H8C8	rats	after	16	
weeks	(P	=	0.04),	although	there	was	no	significant	difference	between	the	three	groups	
at	8	weeks.	While	total	lean	mass	was	significantly	lower	in	the	C	rats	at	8	weeks	(P	=	
0.01),	this	increased	and	was	similar	to	both	the	H	and	H8C8	rats	at	16	weeks.	Total	fat	
mass	was	similar	among	the	C,	H	and	H8C8	groups	at	8	weeks	but	after	16	weeks,	there	
was	a	significant	difference	between	all	three	groups	due	to	an	increase	in	fat	mass	for	
the	 H	 and	 H8C8	 rats	 (P	 <	 0.0001).	 The	 C	 rats	 had	 a	 significantly	 lower	 abdominal	
circumference	compared	 to	 the	H	and	H8C8	rats	at	both	8	and	16	weeks	 (P	<	0.001).	
Despite	 having	 a	 similar	 abdominal	 circumference	 at	 8	 weeks,	 the	 H	 group	 had	 a	
significantly	 greater	 abdominal	 circumference	 than	 the	H8C8	 group	 at	 16	weeks	 (P	 <	
0.0001).		
	
Visceral	adiposity	was	significantly	lower	for	the	C	and	H8C8	rats	than	the	H	rats	at	16	
weeks	(P	<	0.0001).	Total	abdominal	fat	tissue,	including	retroperitoneal,	epididymal	and	
omental	fat	pads,	was	significantly	greater	in	the	H	rats	compared	to	the	C	and	H8C8	rats	
(P	<	0.0001).	The	H	rats	also	had	a	higher	interscapular	brown	fat	weight	than	the	C	and	
H8C8	rats	(P	=	0.04).	The	heart	tissue	weight,	separated	into	left	ventricle	with	septum	
and	right	ventricle,	was	similar	between	the	C,	H	and	H8C8	groups,	as	was	the	weight	of	
the	spleen.	In	contrast,	the	liver	and	kidneys	of	the	H	rats	weighed	significantly	more	than	
those	of	the	C	and	H8C8	rats	(P	<	0.001).	
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Table	3‐3.	Effects	of	switching	diet	on	body	composition	
Variable	 C	 H	 H8C8	 P–value	
Bone	mineral	content	at	8	weeks	
(g)	 12.0	±	0.4	 13.4	±	0.6	 12.5	±	0.5	 0.1436	
Bone	mineral	content	at	16	
weeks	(g)	 13.9	±	0.7	b	 15.8	±	0.4	a	 14.0	±	0.6	b	 0.0382	
Bone	mineral	density	at	8	weeks	
(g/cm2)	 0.172	±	0.002	 0.179	±	0.003	 0.176	±	0.003	 0.1436	
Bone	mineral	density	at	16	
weeks	(g/cm2)	 0.178	±	0.002	 0.178	±	0.003	 0.181	±	0.003	 0.6994	
Total	lean	mass	at	8	weeks	(g)	 269	±	7	b	 306	±	12	a	 300	±	9	a	 0.0119	
Total	lean	mass	at	16	weeks	(g)	 293	±	4	 301	±	9	 305	±	10	 0.5852	
Total	fat	mass	at	8	weeks	(g)	 90	±	8	 128	±	12	 113	±	13	 0.0633	
Total	fat	mass	at	16	weeks	(g)	 89	±	5	c	 189	±	6	a	 125	±	12	b	 <	0.0001	
Abdominal	circumference	at	8	
weeks	(cm)	 18.9	±	0.5	b	 21.4	±	0.4	a	 20.2	±	0.3	a	 0.0006	
Abdominal	circumference	at	16	
weeks	(cm)	 19.4	±	0.2	c	 22.3	±	0.2	a	 20.3	±	0.2	b	 <	0.0001	
Visceral	adiposity	index	(%)	 5.6	±	0.3	b	 8.6	±	0.3	a	 5.7	±	0.4	b	 <	0.0001	
Tissue	wet	weight	at	16	weeks	(mg/mm	tibial	length)	
Retroperitoneal	fat	 241.4	±	9.8	b	 466.0	±	18.6	a	 253.9	±	21.6	b	 <	0.0001	
Epididymal	fat	 107.7	±	7.7	b	 183.2	±	14.5	a	 109.6	±	14.2	b	 0.0001	
Omental	fat	 141.4	±	8.2	b	 227.5	±	7.7	a	 149.6	±	12.8	b	 <	0.0001	
Total	abdominal	fat	 490.5	±	20.2	b	 876.7	±	23.0	a	 513.1	±	45.4	b		 <	0.0001	
Interscapular	brown	fat	 29.1	±	2.3	b	 37.1	±	2.0	a	 29.5	±	1.7	b	 0.0432	
Left	ventricle	and	septum	 23.0	±	0.9	 23.3	±	1.1	 22.3	±	0.9	 0.7484	
Right	ventricle	 5.0	±	0.3	 5.0	±	0.2	 4.9	±	0.3	 0.8679	
Spleen	 17.7	±	0.8	 18.5	±	0.7	 17.1	±	0.8	 0.4560	
Liver	 242.1	±	6.2	b	 333.2	±	8.2	a	 259.5	±	6.7	b		 <	0.0001	
Kidneys	 57.6	±	2.3	b	 63.8	±	1.5	a	 54.4	±	1.0	b	 0.0012	
Values	are	mean	±	SEM,	n	=	10‐12.	Means	in	a	row	with	unlike	superscripts	differ	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8
weeks.	
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There	were	no	significant	differences	 in	bone	mineral	density	and	content,	 lean	mass,	
total	fat	mass	and	abdominal	circumference	among	the	H8,	H8C1,	H8C2,	H8C4	and	H8C8	
groups	 (Table	3–4).	Visceral	 adiposity	and	 retroperitoneal	 fat	mass	were	 significantly	
lower	 for	 the	H8C8	rats	 than	 the	H8	rats	 (P	<	0.05),	while	 the	H8C1,	H8C2	and	H8C4	
groups	had	similar	intermediate	values.	All	four	diet	switch	groups	had	significantly	less	
omental	fat	tissue	than	the	H8	rats,	and	there	was	also	a	significant	reduction	in	omental	
fat	mass	for	the	H8C8	rats	in	comparison	to	the	H8C1	rats	(P	<	0.0001).	Total	abdominal	
fat	consistently	decreased	at	each	time	point	after	the	change	in	diet	and	the	H8C8	rats	
had	a	significantly	lower	abdominal	fat	mass	than	both	the	H8	and	H8C1	rats	(P	<	0.01).	
Although	there	was	no	significant	variation	in	interscapular	brown	fat,	heart	tissue	and	
spleen	mass,	 the	 liver	and	kidney	weights	were	significantly	 lower	 for	 the	diet	 switch	
groups	than	the	H8	group	(P	<	0.01).	
	
	
3.3	 Metabolic	variables		
The	H	group	had	a	significantly	greater	area	under	curve	(AUC)	and	fasting	blood	glucose	
concentration	than	the	C	and	H8C8	groups	at	week	16	(P	<	0.02),	which	is	indicative	of	
reduced	insulin	sensitivity	(Table	3–5).	Plasma	liver	enzymes	were	higher	in	the	H	rats	
and	there	was	a	significant	increase	in	aspartate	transaminase	(AST)	compared	to	the	C	
and	H8C8	rats.	While	there	were	no	significant	differences	in	total	cholesterol,	the	plasma	
triglycerides	and	non‐esterified	fatty	acids	(NEFA)	were	significantly	lower	in	the	C	and	
H8C8	groups	compared	to	the	H	group	(P	<	0.01).	
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Table	3‐4.	Time‐dependent	effects	of	switching	diet	on	body	composition	
Variable	 H8	 H8C1	 H8C2	 H8C4	 H8C8	 P–value	
Bone	mineral	content	(g)	 12.9	±	0.4	 13.6	±	0.6		 13.5	±	0.6	 14.2	±	0.7	 14.0	±	0.6	 0.6456	
Bone	mineral	density	(g/cm2)	 0.177	±	0.004	 0.183	±	0.003	 0.185	±	0.003	 0.182	±	0.004	 0.181	±	0.003	 0.6630	
Total	lean	mass	(g)	 310	±	9	 307	±	7	 310	±	9	 300	±	11	 305	±	10	 0.9350	
Total	fat	mass	(g)	 127	±	13	 123	±	17	 115	±	13	 135	±	17	 125	±	12	 0.9260	
Abdominal	circumference	(cm)	 20.2	±	0.2	 20.1	±	0.4	 20.3	±	0.3	 20.5	±	0.3	 20.3	±	0.2	 0.9018	
Visceral	adiposity	(%)	 8.0	±	0.4	a	 6.9	±	0.5	ab	 6.6	±	0.3	ab	 6.8	±	0.4	ab	 5.7	±	0.4	b	 0.0054	
Tissue	wet	weight	(mg/mm	tibial	length)	
Retroperitoneal	fat	 394.6	±	32.8	a	 341.8	±	31.2	ab	 334.9	±	25.2	ab	 330.2	±	27.5	ab	 253.9	±	21.6	b	 0.0219	
Epididymal	fat	 142.2	±	9.9	 156.4	±	14.9	 142.1	±	12.6	 124.5	±	13.4	 109.6	±	14.2	 0.1215	
Omental	fat	 251.2	±	11.1	a	 204.4	±	16.7	b	 176.2	±	12.8	bc	 184.3	±	10.7	bc	 149.6	±	12.8	c	 <	0.0001	
Total	abdominal	fat	 787.9	±	47.1	a	 694.7	±	62.2	a	 653.2	±	34.1	ab	 639.0	±	45.9	ab	 513.1	±	45.4	b	 0.0055	
Interscapular	brown	fat	 32.8	±	2.1	 27.0	±	2.1	 27.1	±	2.1	 27.8	±	1.9	 29.5	±	2.3	 0.2269	
Left	ventricle	and	septum	 22.6	±	1.3	 24.8	±	1.0	 25.5	±	0.7	 24.8	±	1.3	 22.3	±	0.9	 0.1158	
Right	ventricle	 4.9	±	0.4	 5.7	±	0.2	 5.0	±	0.4	 5.0	±	0.5	 4.9	±	0.3	 0.1749	
Spleen	 18.8	±	0.9	 16.8	±	0.8	 16.8	±	0.7	 16.8	±	1.2	 17.1	±	0.8	 0.4490	
Liver	 314	±	7.8	a	 261	±	10.3	b	 276	±	11.8	b	 244	±	11.5	b	 260	±	6.7	b	 0.0001	
Kidneys	 60.5	±	1.7	a	 54.4	±	1.3	b	 55.5	±	1.2	b	 54.1	±	1.5	b	 54.4	±	1.0	b	 0.0077	
Values	are	mean	±	SEM,	n	=	10‐12.	Mean	in	a	row	with	unlike	superscripts	differ	significantly	(P	<	0.05).	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	
1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	high‐
fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;	H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	
diet	for	8	weeks.	
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AUC	was	significantly	lower	in	the	H8C4	rats	in	comparison	to	the	H8C2	and	H8C8	rats	
(P	<	0.05),	while	the	AUC	of	the	H8	and	H8C1	rats	did	not	differ	from	the	other	groups	
significantly	 (Table	 3–6).	 A	 significant	 decrease	 in	 alanine	 transaminase	 (ALT)	 was	
observed	 for	 the	 H8C4	 rats	 in	 comparison	 to	 the	 H8C1	 rats	 (P	 <	 0.05)	 and	 although	
aspartate	transaminase	(AST)	was	noticeably	lower	for	the	H8C8	rats	compared	to	the	
H8,	H8C1,	H8C2	 and	H8C4	 rats,	 these	 changes	were	not	 statistically	 significant.	 Total	
cholesterol	was	significantly	greater	for	the	H8	rats	in	comparison	to	the	H8C1	and	H8C8	
rats	 (P	 <	 0.0001).	 The	 H8C1	 group	 also	 had	 a	 significantly	 lower	 total	 cholesterol	
concentration	compared	to	the	H8C2	and	H8C4	groups.	There	was	a	significant	reduction	
in	plasma	NEFA	concentrations	for	the	H8C8	rats	in	comparison	to	the	H8	rats	(P	=	0.05)	
and	the	plasma	triglyceride	concentration	was	51%	lower	in	the	H8C1	group	than	the	H8	
group	(P	<	0.001).	These	plasma	triglyceride	concentrations	were	maintained	in	the	H8C2	
rats	and	decreased	slightly	further	in	the	H8C4	and	H8C8	rats.	
Table	3‐5.	Effects	of	switching	diet	on	glucose	tolerance,	plasma	liver	enzymes	and
lipid	profile	at	16	weeks	
Variable	 C	 H	 H8C8	 P–value	
Glucose	tolerance	
Area	under	curve	(mmol/min) 625	±	31	b	 734	±	33	a	 595	±	24	b	 0.0062	
Plasma	liver	enzymes	
Alanine	transaminase	(U/L)	 31	±	4	 53	±	10	 35	±	10	 0.1780	
Aspartate	transaminase	(U/L)	 84	±	3	b	 131	±	19	a	 85	±	6	b	 0.0438	
Plasma	lipid	profile	
Total	cholesterol	(mmol/L)	 1.60	±	0.14	 1.79	±	0.09	 1.33	±	0.09	 0.0688	
Triglycerides	(mmol/L)	 0.81	±	0.05	b	 1.78	±	0.27	a	 0.60	±	0.19	b	 0.0058	
Non‐esterified	fatty	acids	
(mmol/L)	 1.5	±	0.1	b	 3.9	±	0.6	a	 1.3	±	0.2	b	 0.0027	
Values	are	mean	±	SEM,	n	=	3‐12.	Means	in	a	row	with	unlike	superscripts	differ	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	
weeks.	
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Table	3‐6.	Time‐dependent	effects	of	switching	diet	on	glucose	tolerance,	plasma	liver	enzymes	and	lipid	profile	
Variable	 H8	 H8C1	 H8C2	 H8C4	 H8C8	 P–value	
Glucose	tolerance	
Area	under	curve	(mmol/min)	 543	±	16	ab	 544	±	13	ab	 579	±	12	a	 498	±	9	b	 595	±	24	a	 0.0021	
Plasma	liver	enzymes	
Alanine	transaminase	(U/L)	 40	±	2	ab	 45	±	3	a	 37	±	2	ab	 31	±	3	b	 35	±	1	ab	 0.0145	
Aspartate	transaminase	(U/L)	 103	±	4	 109	±	6	 105	±	5	 101	±	5	 85	±	6	 0.2732	
Plasma	lipid	profile	
Total	cholesterol	(mmol/L)	 1.72	±	0.06	a	 1.30	±	0.07	b	 1.63	±	0.05	ac	 1.52	±	0.05	ac	 1.33	±	0.09	bc	 <	0.0001	
Triglycerides	(mmol/L)	 1.47	±	0.24	a	 0.72	±	0.10	b	 0.74	±	0.09	b	 0.66	±	0.09	b	 0.60	±	0.19	b	 0.0008	
Non‐esterified	fatty	acids	
(mmol/L)	 2.9	±	0.4	a	 2.1	±	0.2	ab	 1.8	±	0.3	ab	 1.9	±	0.3	ab	 1.3	±	0.2	b	 0.0502	
Values	are	mean	±	SEM,	n	=	3‐12.	Means	in	a	row	with	unlike	superscripts	differ	significantly	(P	<	0.05).	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	
for	1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	
high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;	H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	
starch	diet	for	8	weeks.	
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The	diet	 switch	had	a	 significant	effect	on	respiratory	exchange	 ratio	 (RER),	 the	 ratio	
between	the	volume	of	oxygen	utilised	and	carbon	dioxide	produced	during	metabolic	
functions	(Figure	3–2).	RER	was	significantly	lower	when	rats	were	fed	the	HCHF	diet	in	
comparison	to	the	CS	diet	(P	<	0.001),	which	was	particularly	evidenced	by	the	increase	
in	RER	 for	 the	H8C8	rats	after	 the	diet	 switch	(Figure	3–2A).	These	changes	occurred	
within	the	first	week	of	switching	diet,	as	RER	was	significantly	greater	in	the	H8C1	rats	
compared	the	H8	rats	(P	<	0.0001)	(Figure	3–2B).	This	higher	RER	was	maintained	in	the	
H8C2	and	H8C4	rats,	then	significantly	increased	further	in	the	H8C8	rats.		
	
	
	
	
	
	
	
	
	
	
	
Figure	 P–value	
A	–	week	8	 0.0008	
A	–	week	16	 <	0.0001	
B	 <	0.0001	
Figure	3‐2.	Effects	of	switching	diet	on	respiratory	exchange	ratio	at	8	and	16	weeks
(A)	and	at	varying	time	points	(B)	
Values	are	mean	±	SEM,	n	=	4–6.	Means	with	an	uncommon	letter	differ	significantly	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	
diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐
fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	
high‐fat	 diet	 for	 8	 weeks	 then	 switched	 to	 a	 corn	 starch	 diet	 for	 4	 weeks;	H8C8,	 rats	 fed	 a	 high‐
carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks.	
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Indirect	 calorimetry	was	also	used	 to	measure	heat	production,	which	 is	displayed	 in	
Figure	3–3.	Although	the	H	rats	consistently	produced	more	heat	than	the	H8C8	and	C	
rats	(approximately	4.5	kcal/hour	in	comparison	to	4.2	and	3.8	kcal/hour,	respectively),	
the	heat	production	was	only	significantly	greater	for	the	H	rats	in	comparison	to	the	C	
rats	at	16	weeks	(P	<	0.05)	(Figure	3–3A).	Heat	production	was	unchanged	in	the	H8C8	
rats	after	the	diet	switch	and	there	were	also	no	significant	differences	in	heat	production	
among	the	H8,	H8C1,	H8C2,	H8C4	and	H8C8	groups	(P	=	0.08)	(Figure	3–3B).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 P–value	
A	–	week	8	 0.1102	
A	–	week	16	 0.0322	
B	 0.0804	
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Figure	3‐3.	Effects	of	switching	diet	on	heat	production	at	8	and	16	weeks	(A)	and	at
varying	time	points	(B)	
Values	are	mean	±	SEM,	n	=	4–6.	Means	with	an	uncommon	letter	differ	significantly	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	
diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	1	week;	H8C2,	rats	fed	a	high‐carbohydrate,	high‐
fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	
high‐fat	 diet	 for	 8	 weeks	 then	 switched	 to	 a	 corn	 starch	 diet	 for	 4	 weeks;	H8C8,	 rats	 fed	 a	 high‐
carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks.	
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3.4	 Cardiovascular	structure	and	function	
Systolic	blood	pressure	was	significantly	higher	in	the	HCHF	diet‐fed	rats	compared	to	
rats	fed	the	CS	diet	(Figure	3–3).	The	systolic	blood	pressure	of	the	H8C8	rats	was	similar	
to	 the	H	 rats	 (approximately	135–140	mmHg)	at	8	weeks	and	significantly	decreased	
after	 the	 diet	 switch,	 reaching	 a	 similar	 value	 to	 the	 C	 rats	 (approximately	 120–125	
mmHg)	at	16	weeks	(P	<	0.0001)	(Figure	3–3A).	The	decrease	in	systolic	blood	pressure	
after	the	diet	switch	was	also	observed	in	the	H8C4	group,	which	was	significantly	lower	
than	the	H8	rats	and	similar	to	the	H8C8	rats	(P	<	0.0001)	(Figure	3–3B).	
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Figure	3‐4.	Effects	of	switching	diet	on	systolic	blood	pressure	at	8	and	16	weeks	(A)
and	at	varying	time	points	(B)	
Values	are	mean	±	SEM,	n	=	6–11.	Means	with	an	uncommon	letter	differ	significantly	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C4,	rats	fed	a	high‐carbohydrate,	high‐fat	
diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;	H8C8,	rats	fed	a	high‐carbohydrate,	
high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks.	
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The	diastolic	stiffness	constant	(κ,	dimensionless)	was	significantly	greater	for	the	H	rats	
in	comparison	to	the	C	and	H8C8	rats	at	16	weeks	(P	<	0.0001)	(Figure	3–4A).	The	effects	
of	the	diet	switch	were	apparent	after	two	weeks	of	consuming	the	CS	diet,	with	the	H8C2,	
H8C4	and	H8C8	groups	having	a	significantly	decreased	diastolic	stiffness	in	comparison	
to	the	H8	and	H8C1	groups	(P	<	0.0001)	(Figure	3–4B).	
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Figure	3‐5.	Effects	of	switching	diet	on	diastolic	stiffness	at	16	weeks	(A)	and	at
varying	time	points	(B)	
Values	are	mean	±	SEM,	n	=	5–10.	Means	with	an	uncommon	letter	differ	significantly	(P	<	0.05).		
C,	rats	fed	a	corn	starch	diet	for	16	weeks;	H,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	16	weeks;	
H8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks;	H8C1,	rats	fed	a	high‐carbohydrate,	high‐
fat	 diet	 for	 8	 weeks	 then	 switched	 to	 a	 corn	 starch	 diet	 for	 1	 week;	 H8C2,	 rats	 fed	 a	 high‐
carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks;	H8C4,	rats	
fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	4	weeks;
H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	
8	weeks.	
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Microscopically,	the	C	rats	had	no	obvious	signs	of	heart	inflammation,	whereas	the	H	rat	
hearts	 contained	 large	 clusters	 of	 inflammatory	 cells	 (Figure	 3–5).	 The	 diet	 switch	
noticeably	reduced	inflammatory	cell	 infiltration	and	the	heart	tissue	of	the	H8C8	rats	
appeared	similar	 to	 the	C	rats	at	 the	end	of	 the	16–week	protocol.	These	effects	were	
apparent	 two	 weeks	 after	 changing	 diet,	 as	 the	 H8C2	 rats	 had	 considerably	 fewer	
inflammatory	cells	in	comparison	to	the	H8	and	H8C1	rats,	and	the	heart	inflammation	
continued	to	improve	in	the	H8C4	and	H8C8	rats	(Figure	3–6).		
	
	
	
	
Figure	3‐6.	Effects	of	switching	diet	on	heart	inflammation	
A–C	represents	haematoxylin	and	eosin	staining	of	the	heart	showing	inflammatory	cells	(marked	as
‘IC’)	(20×).	C,	rats	fed	a	corn	starch	diet	for	16	weeks	(A);	H,	rats	fed	a	high–carbohydrate,	high–fat	
diet	for	16	weeks	(B);	H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	
a	corn	starch	diet	for	8	weeks	(C).	
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Figure	3‐7.	Time–dependent	effects	of	switching	diet	on	heart	inflammation	
A–C	represents	haematoxylin	and	eosin	staining	of	the	heart	showing	inflammatory	cells	(marked	as	‘IC’)	(20×).	H8,	rats	fed	a	high–carbohydrate,	high–fat	diet	for	8
weeks	(A);	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	1	week	(B);	H8C2,	rats	fed	a	high‐carbohydrate,	high‐fat	
diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks	(C);	H8C4,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	
4	weeks	(D);		H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks	(E).	
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3.5	 Liver	structure	
The	H	rats	had	extensive	 lipid	deposition	and	inflammatory	cell	 infiltration	within	the	
liver,	while	the	C	rats	showed	no	signs	of	hepatic	inflammation	or	steatosis	(Figure	3–7).	
The	liver	tissue	from	the	H8C8	rats	appeared	more	similar	to	the	C	rats	histologically,	
although	 there	were	 small	 fat	 vacuoles	 and	 clusters	 of	 inflammatory	 cells.	 There	was	
widespread	lipid	deposition	within	the	livers	of	the	H8	and	H8C1	rats,	which	was	visibly	
reduced	within	the	H8C2	rat	livers	and	continued	to	improve	in	the	H8C4	and	H8C8	rats	
(Figure	 3–8).	 Liver	 inflammation	 persisted	 after	 the	 decrease	 in	 fat	 deposition,	 as	
inflammatory	cells	were	still	present	within	the	H8C4	and	H8C8	rats.		
	
	
	
	
	
	
	
	
Figure	3‐8.	Effects	of	switching	diet	on	liver	inflammation	and	fat	deposition	
A–C	represents	haematoxylin	and	eosin	staining	of	the	liver	showing	inflammatory	cells	(marked	as	
‘IC’)	and	fat	vacuoles	(marked	as	‘FV’)	(20×).	C,	rats	fed	a	corn	starch	diet	for	16	weeks	(A);	H,	rats	fed	
a	high–carbohydrate,	high–fat	diet	for	16	weeks	(B);	H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	
for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks	(C).	
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Figure	3‐9.	Time–dependent	effects	of	switching	diet	on	liver	inflammation	and	fat	deposition	
A–C	represents	haematoxylin	and	eosin	staining	of	the	liver	showing	inflammatory	cells	(marked	as	‘IC’)	and	fat	vacuoles	(marked	as	‘FV’)	(20×).	H8,	rats	fed	a	high–
carbohydrate,	high–fat	diet	for	8	weeks	(A);	H8C1,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	1	week	(B);	H8C2,	rats	
fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	2	weeks	(C);	H8C4,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	
switched	to	a	corn	starch	diet	for	4	weeks	(D);		H8C8,	rats	fed	a	high‐carbohydrate,	high‐fat	diet	for	8	weeks	then	switched	to	a	corn	starch	diet	for	8	weeks	(E).	
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Chapter	4. 	 Discussion	
This	 study	 investigated	 the	 attenuation	 of	 diet–induced	 metabolic	 syndrome	 in	 rats	
switched	from	a	diet	rich	in	simple	carbohydrates	and	saturated	fats	to	a	 low–fat,	 less	
energy–dense	diet.	Consumption	of	the	HCHF	diet	for	8	weeks	induced	the	characteristic	
traits	 of	metabolic	 syndrome,	 including	 increased	 abdominal	 adiposity,	 hypertension,	
glucose	 intolerance	 and	 hypertriglyceridemia.	 These	 symptoms	 worsened	 with	
prolonged	HCHF	diet	feeding,	as	visceral	adiposity,	plasma	lipids,	OGTT	AUC	and	diastolic	
stiffness	continued	to	increase.	In	contrast,	rats	fed	the	CS	diet	for	16	weeks	displayed	no	
signs	of	metabolic,	cardiovascular	or	liver	dysfunction.	Switching	to	the	CS	diet	rapidly	
reversed	several	signs	of	HCHF	diet–induced	metabolic	syndrome,	despite	the	minimal	
reduction	in	overall	body	weight.	Within	one	week	of	the	diet	switch,	omental	fat	mass	
had	decreased,	the	liver	and	kidneys	weighed	significantly	less,	there	was	an	increase	in	
RER	and	a	50%	reduction	in	plasma	triglycerides.	Diastolic	stiffness,	heart	inflammation	
and	liver	fat	deposition	significantly	decreased	after	two	weeks	of	consuming	the	CS	diet	
and	systolic	blood	pressure	was	reduced	within	four	weeks	of	the	diet	switch.	Although	
weight	regain	occurred	4–6	weeks	after	changing	diet,	there	was	a	significant	reduction	
in	visceral	adiposity,	decrease	in	plasma	NEFA	concentration	and	an	additional	increase	
in	RER	by	the	end	of	the	16–week	protocol.		
	
Symptoms	of	metabolic	syndrome	were	apparent	after	feeding	rats	the	HCHF	diet	for	at	
least	8	weeks,	which	 is	 consistent	with	previous	 studies	 that	have	utilised	 this	model	
(Bhaswant	et	al.	2015;	Panchal	et	al.	2011;	Wanyonyi	et	al.	2017).	The	obesogenic	nature	
of	the	HCHF	diet	is	not	only	due	to	the	high	content	of	trans	and	saturated	fats	in	the	beef	
tallow,	 as	 fructose	has	also	been	 strongly	 implicated	 in	 the	development	of	metabolic	
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syndrome	 (Bahadoran	 et	 al.	 2017;	 Ishimoto	 et	 al.	 2013;	 Lozano	 et	 al.	 2016).	 Despite	
having	 a	 similar	 molecular	 structure	 to	 glucose	 and	 an	 equivalent	 caloric	 value,	 the	
metabolism	of	 fructose	differs	slightly.	While	glucose	metabolism	 is	dependent	on	 the	
enzyme	phosphofructokinase	(PFK),	which	catalyses	the	rate–limiting	step	of	glycolysis,	
fructose	is	primarily	metabolised	by	the	liver–specific	enzyme	fructokinase	(Ishimoto	et	
al.	2013;	Lyssiotis	&	Cantley	2013).	The	fructose	metabolic	pathway	therefore	bypasses	
a	crucial	PFK–mediated	regulatory	mechanism	that	 limits	the	conversion	of	glucose	to	
substrates	for	de	novo	lipogenesis,	and	this	lack	of	inhibitory	feedback	allows	unrestricted	
conversion	of	excess	fructose	to	fatty	acids	for	storage	within	adipose	tissues	(Lyssiotis	
&	Cantley	2013;	 Schwarz	et	 al.	 2015).	Unlike	glucose,	 fructose	does	not	 stimulate	 the	
release	of	insulin	and	other	satiety	signals,	such	as	glucagon–like	peptide–1	(GLP–1)	and	
gastric	inhibitory	polypeptide	(GIP),	which	diminishes	appetite	suppression	after	a	meal	
(Wölnerhanssen	et	al.	2015).	Fructose	also	strongly	activates	brain	regions	associated	
with	food	reward,	promoting	greater	energy	intake	that	in	turn	contributes	to	weight	gain	
and	increased	adiposity	(Luo	et	al.	2015;	Wölnerhanssen	et	al.	2015).	Excessive	fructose	
consumption	has	been	implicated	in	the	development	of	leptin	resistance	and	is	rapidly	
reversed	 after	 switching	 to	 a	 sugar–free	 diet,	 even	 one	 that	 is	 rich	 in	 saturated	 fats	
(Shapiro	et	al.	2011).	
	
Daily	energy	intake	rapidly	decreased	after	switching	to	the	CS	diet,	which	is	similar	to	
observations	from	previous	studies	investigating	the	effects	of	switching	mice	from	an	
obesogenic	diet	to	a	standard	chow	diet	(Guo	et	al.	2009;	Kowalski	et	al.	2016;	Ma,	Gao	&	
Liu	2016).	The	reduced	caloric	intake	in	this	study	was	not	enforced	by	restricting	food	
availability,	as	the	rats	were	provided	ad	libitum	access	to	food	throughout	the	protocol	
duration,	and	 food	 intake	 increased	after	 the	diet	 switch	 to	compensate	 for	 the	 lower	
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energy	density	of	the	CS	diet	(11.23	kJ/g	compared	to	17.83	kJ/g	for	the	HCHF	diet).	Food	
intake	is	mediated	by	gastrointestinal	neuroendocrine	signals,	which	are	relayed	to	the	
brain	via	the	vagus	nerve	and	convey	information	about	the	type	and	quantity	of	ingested	
nutrients	(Begg	&	Woods	2013).	Vagal	nerve	fibres	express	chemoreceptors,	which	are	
stimulated	by	gut	hormones	secreted	from	specialised	enteroendocrine	cells	throughout	
the	 gastrointestinal	 tract,	 and	mechanoreceptors	 that	 sense	distension	 as	 food	passes	
through	the	stomach	and	intestines	during	digestion	(de	Lartigue	2016).	Diet–induced	
obesity	alters	the	vagal	response	to	gut	hormone	signalling	and	reduces	the	sensitivity	to	
gastrointestinal	distension	(Daly	et	al.	2011;	Kentish	et	al.	2012).		
	
Previous	studies	have	reported	prolonged	changes	 in	appetite	after	switching	from	an	
obesogenic	 diet	 to	 a	 low–fat	 diet	 and	 this	 has	 been	 attributed	 to	 the	 incomplete	
restoration	 of	 vagal	 nerve	 sensitivity	 and	 increased	 levels	 of	 the	 orexigenic	 hormone	
ghrelin	(Briggs	et	al.	2013;	Kentish	et	al.	2014;	Sumithran	et	al.	2011).	In	contrast,	the	diet	
switch	rats	in	this	study	did	not	appear	to	have	a	dramatic	increase	in	hunger	or	lasting	
satiety	impairment.	Although	weight	regain	occurred	in	the	H8C8	within	four	weeks	of	
switching	to	the	CS	diet,	the	daily	food	intake	remained	equivalent	to	the	C	rats.	Rather	
than	the	weight	gain	reflecting	an	adaptive	response	to	counteract	additional	weight	loss,	
as	has	been	previously	suggested	(Fothergill	et	al.	2016;	Guo	et	al.	2009;	Sumithran	et	al.	
2011),	this	could	instead	be	due	to	ongoing	growth	and	development	of	the	young	rats	
since	the	weight	gain	was	parallel	to	the	C	rats	after	adjusting	to	the	CS	diet.	Similarly,	a	
study	by	Hoevenaars	et	al.	(2013)	found	that	energy	intake	and	expenditure	reflected	the	
most	 recently	 consumed	 diet	 without	 any	 influence	 from	 previous	 consumption	 of	 a	
high–fat	diet.		
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Despite	the	lack	of	statistically	significant	weight	loss,	there	were	considerable	metabolic	
improvements	following	the	diet	switch.		
	
 The	decrease	in	visceral	adiposity	suggests	that	there	was	an	increase	in	lipolysis	and	
since	plasma	triglycerides	and	NEFA	decreased,	 the	energy	was	being	utilised.	The	
oxymax	results	showed	an	increase	in	RER,	suggesting	that	the	main	source	of	energy	
was	carbohydrates	(since	the	CS	diet	is	high	in	carbohydrates	and	low	in	fats).	There	
was	also	no	decrease	in	heat	production	after	the	diet	switch,	so	the	rats	continued	to	
release	the	same	amount	of	energy	as	heat	despite	the	reduced	energy	intake.	
 The	reduction	in	visceral	adiposity	observed	in	this	study	is	consistent	with	similar	
studies	that	investigated	mild	calorie	restriction	(Park	et	al.	2017).	
 OGTT	AUC	results	in	this	study	were	highly	variable,	so	an	alternative,	more	reliable	
method	of	measuring	this	could	be	an	insulin	tolerance	test	or	insulin	resistance	test	
(HOMA‐IR)	
	
Cardiovascular	improvements		
 The	obesity–related	increase	in	leptin	has	been	associated	with	hypertension,	due	to	
increased	 sympathetic	 nervous	 system	 activity	 mediated	 by	 the	 dorsomedial	
hypothalamus	 (this	 also	 increases	 BAT	 thermogenesis).	Mice	 lacking	 leptin	 or	 the	
leptin	receptor	are	hypotensive	despite	being	severely	obese	(lack	of	leptin	signalling	
impairs	satiety,	so	food	intake	is	increased).	Systolic	blood	pressure	decreased	two	
weeks	after	HFD	diet–induced	obese	mice	were	switched	back	to	a	chow	diet,	which	
correlated	with	decreases	in	body	weight	and	leptin	(Simonds	et	al.	2014).	
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 Angiotensin	is	also	released	from	adipose	tissue,	further	contributing	to	hypertension	
and	ventricular	hypertrophy.	
 Increased	fatty	acid	oxidation	in	obesity	leads	to	diastolic	dysfunction	(Rayner	et	al.	
2018).	 The	 diet	 switch	 may	 have	 reduced	 diastolic	 stiffness	 due	 to	 a	 change	 in	
myocardial	energetics	(Rider	et	al.	2013).		
 Consumption	 of	 a	 high‐fructose	 diet	 has	 been	 shown	 to	 increase	 the	 activation	 of	
apoptosis	and	suppress	survival	pathways	in	cardiac	myocytes	
 Fat	infiltration	within	the	heart	can	also	induce	myocyte	damage	and	fibrosis,	which	
contributes	to	the	development	of	diastolic	stiffness	and	heart	failure.	
 Discuss	the	mechanisms	involved	in	reducing	hepatic	steatosis	and	the	health	benefits	
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Chapter	5. 	 Conclusions	
This	study	investigated	the	sequence	of	metabolic,	cardiovascular	and	hepatic	changes	
that	occur	during	the	attenuation	of	diet–induced	metabolic	syndrome.	The	main	finding	
was	 that	switching	 from	the	HCHF	diet	 to	 the	CS	diet	 led	 to	a	 reduction	 in	abdominal	
adiposity,	which	subsequently	decreased	fat	deposition	within	the	liver,	reduced	heart	
inflammation,	 improved	diastolic	 function	and	 lowered	systolic	blood	pressure.	These	
health	benefits	occurred	despite	minimal	weight	loss	after	the	diet	switch,	which	suggests	
that	diet	and	body	composition	have	a	more	 important	 role	 in	determining	metabolic	
health	and	cardiovascular	risk	than	body	weight	alone.	While	the	effects	of	switching	diet	
were	rapidly	seen	in	rats,	further	research	will	be	required	to	ascertain	how	these	results	
translate	to	humans.	
43	
Chapter	6. 	 Future	directions	
To	provide	further	insight	into	how	the	diet	switch	affected	the	regulation	of	adiposity,	
an	 enzyme–linked	 immunosorbent	 assay	 (ELISA)	 could	 be	 performed	 on	 the	 plasma	
samples	collected	 in	this	study	to	analyse	satiety	hormone	concentrations.	The	rate	at	
which	 obesity–induced	 leptin	 and	 ghrelin	 resistance	 is	 reversed	 after	 weight	 loss	 is	
unclear,	so	this	study	could	provide	a	better	understanding	of	how	this	occurs	over	time.	
	
In	addition,	the	samples	of	white	(retroperitoneal),	beige	(inguinal)	and	brown	adipose	
tissues	 collected	 in	 this	 study	 could	be	used	 to	determine	whether	 the	 change	 in	diet	
induced	adipose	tissue	browning/beiging.	Beige	and	brown	adipocytes	are	distinct	from	
white	adipocytes	due	to	the	expression	of	uncoupling	protein–1	(UCP–1),	which	regulates	
the	process	of	adaptive	or	“non–shivering”	thermogenesis	and	causes	the	mitochondria	
to	release	energy	as	heat	rather	than	ATP	(Qiang	et	al.	2012).	To	observe	the	changes	in	
UCP–1	expression	at	the	cellular	level,	immunohistochemistry	could	be	performed	on	the	
adipose	tissue	samples	collected	for	histology.	The	retroperitoneal	fat	samples	could	also	
be	used	to	determine	if	the	diet	switch	reduced	adipocyte	hypertrophy	in	white	adipose	
tissue,	which	would	involve	histology	using	haematoxylin	and	eosin	staining.	
	
Reverse	 transcription	 polymerase	 chain	 reaction	 (RT‐PCR)	 could	 provide	 additional	
insight	into	the	molecular	changes	that	occur	as	a	result	of	switching	to	the	corn	starch	
diet.	 Specific	 gene	 targets	 relevant	 to	 this	 study	 include	 liver	 enzymes	 involved	 in	
carbohydrate	and	lipid	metabolism,	adenosine	monophosphate–activated	protein	kinase	
(AMPK),	UCP–1,	sirtuin	1	(SIRT1),	peroxisome	proliferator–activated	receptor–γ	(PPAR–
γ)	and	PPAR–γ	coactivator–1α	(PGC–1α).		
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